Essex Property Trust, Inc. (ESS) received a “Market Perform” rating from John Kim at BMO Capital on January 9, 2026, a ...

Summary • Arbe Robotics Ltd. (ARBE) rises 15% in pre-market trading, reaching $1.38 after CES 2026 showcasing. • The company ...

Summary • CeriBell, Inc. (CBLL) jumps 23% in pre-market trading following FDA Breakthrough Device Designation for a stroke ...

HealthEquity, Inc. (HQY) has recently been downgraded to a “Sell” rating by David Roman of Goldman Sachs, with a price target slashed to $89 from earlier estimates. This change comes at a time when ...

Equity Residential (NYSE: EQR) has recently been assigned a “Market Perform” rating by analyst John Kim from BMO Capital, reflecting a cautious outlook for investors amid mixed performance indicators.

MoonLake Immunotherapeutics (MLTX) is garnering attention in the investment community following a recent upgrade to a Buy rating from BTIG analyst Julian Harrison. This bullish outlook comes with a ...

Sotera Health Company (SHC) has recently received an **Overweight** rating from analyst Jason Bednar of Piper Sandler, effective. With a current trading price of **$18.81** and a price target set at * ...

Independence Realty Trust, Inc. (IRT) earned an ‘Outperform’ rating from John Kim at BMO Capital. This upgrade signals confidence in the company’s ability to outperform its peers, particularly with a ...

Cleveland-Cliffs Inc. (CLF) has recently been upgraded to an Overweight rating by Carlos De Alba of Morgan Stanley, a change that could signal a positive outlook for investors. The new price target of ...

In a recent note, BMO Capital analyst Juan Sanabria assigned a “Market Perform” rating to Omega Healthcare Investors, Inc. (NYSE: OHI), indicating a cautious stance on the stock despite a slightly ...

In a notable move for investors, TD Cowen analyst Jeffrey Osborne upgraded SolarEdge Technologies, Inc. (SEDG) to a “Buy” rating on January 9, 2026, with a price target set at $38. This upgrade comes ...

Analysts at Jefferies recently endorsed Donaldson Company, Inc. (DCI) with a “Buy” rating, significantly raising the price target to $120 from a previous estimate of $97.67. This upward revision ...